How Employers Can Prioritize Hypertension Control & Management
Fireside Chat | July 10
One in three working-age adults in the US have hypertension, and direct costs for workers with hypertension are nearly 50% higher than for workers without hypertension. Yet, many employers have not implemented strategies that address high blood pressure control and management. Join experts to learn why employers should implement a HTN initiative, what tools are available to assess the impact of hypertension on health and cost outcomes for their workforce, and what they are currently doing to recognize and address hypertension at work.
HTN Roundtable Annual Summit 2024
Healthy Moms, Healthy Babies, Healthy Nation Summit: Evidence-based Strategies to Prevent & Control Hypertension During Pregnancy
May 23, 2024
On May 23rd, NHCR proudly hosted Roundtable members and maternal hypertension experts in Washington, DC, for its 2024 Healthy Moms, Healthy Babies, Healthy Nation Summit: Evidence-based Strategies to Prevent & Control Hypertension During Pregnancy. This important convening of more than 35 organizations focused on collaboratively and actionably improving patient outcomes across sectors including providers, payers, and researchers. The day they featured compelling presentations, rich discussion, and, crucially, applied strategy on social determinants of health, validated devices, data and technology, care team solutions, the latest Roundtable Initiatives (Payer Taskforce and Team-Based Care Taskforce), and more. The innovations, successes, and shared challenges reviewed at the Summit invigorated the Roundtable’s ongoing commitment to hypertension literacy and equity for patients at every stage of life: Through these critical learnings, the Roundtable looks ahead to future partnership and progress toward increased hypertension control.Matthew Baumgart
Hypertension, Lifestyle Medicine, & Health Equity
Fireside Chat | April 2024
Business Case for Employers Background
Putting People First: Prioritizing Hypertension Care Across Sectors
Hypertension (high blood pressure) affects nearly 50% of working-age adults in the United States. Hypertension is a hidden business risk to employers—undiagnosed and uncontrolled hypertension leads to lost productivity, poor health and well-being, and higher healthcare costs. Hypertension is treatable, and employers are an important catalyst for change to promote equitable well-being for their employees and communities.
The HTN Roundtable invites you to use the following tools to support building the business case for employer engagement in hypertension prevention and control:
- Developing the Business Case for Hypertension Control – Budget Impact Model & Claims Analysis Guide Webinar Watch webinar
- Developing the Business Case for Slide Presentation: Download Slides
- Hypertension Control Budget Impact Model and Claims Analysis Guide Budget Impact Model uses easily accessible data to estimate Hypertension-related costs. Fill out form for access
- Budget Impact Model User Guide Download PDF
- Comprehensive Benefit Design Guide for Hypertension – Recommendations for health & well-being programming, and employee benefits design, as well as annotated resources for employers who would like to develop and implement a hypertension strategy. Download the Guide
- Hypertension Claims Analysis Guide Download PDF
- Infographic: Putting People First: The Benefits of Prioritizing Hypertension Care Download Infographic
- Infographic: Minimizing Business Risk: The Financial Benefits of Hypertension Control and Management Download Infographic
Rationale for Health Plan Hypertension Control Programs
Authored by the HTN Roundtable’s Payer Task Force, this brief paper outlines the rationale for health plan to prioritize their capabilities in comprehensive, evidence-based population health programs to manage hypertension for their members.
Device Listing Tool
United States Blood Pressure Validated Device Listing Tool from the American Medical Association (AMA)
Using this tool, you can search whether an automated blood pressure measurement device meets the appropriate criteria for clinical accuracy.
Hypertension Control: Healthier Moms, Healthier Babies, Healthier Nation
Fireside Chat | February 2024
American Heart Month
February is American Heart Month, a time when everyone is encouraged to prioritize their heart health. This applies to everyone and especially to women! Join the HTN Roundtable Steering Committee for the upcoming National Wear Red Day® and American Heart Month! To learn more about tools to utilize during American Heart Month, please visit CDC’s American Heart Month 2024 Toolkits.
To kick off American Heart Month, make sure you mark your calendars for Friday February 2nd, as National Wear Red Day®!
Pictured: The HTN Roundtable Steering Committee is ready for #National Wear Red Day!
Revealing Regional Trends and Actionable Insights on Hypertension by Leveraging Electronic Health Records of a Large Health System
Fireside Chat | November 2023
Faith-Based Initiatives for Improving Hypertension Control
Fireside Chat | May 2023
Hypertension and Brain Health
Fireside Chat | March 2023
The Value of Team-Based Care to Improve Hypertension
Fireside Chat | February 2023
Modele Ogunniyi, MD
Dr. Modele Ogunniyi is an Associate Professor of Medicine and Master Physician in the Division of Cardiology at Emory University School of Medicine. She is the Associate Medical Director of the Grady Heart Failure Program. She serves as the Co-Chair of the National Hypertension Control Roundtable. After receiving her medical degree from the University of Ibadan, Nigeria, she obtained a Master’s in Public Health and a Health Finance and Management Certificate from Johns Hopkins University. Dr. Ogunniyi completed her postgraduate training in preventive medicine and public health at the Centers for Disease Control and Prevention, a residency in internal medicine at Morehouse School of Medicine, and a cardiology fellowship at Vanderbilt University. Her research focuses on examining social determinants of health and eliminating disparities in cardiovascular disease, specifically hypertension and heart failure, diversity in clinical trials, and cardiovascular disease in women. Dr. Ogunniyi is passionate about mentorship and creating equitable pathways to diversify the workforce in Medicine. In recognition of her efforts, she has received several awards, including the Emory University School of Medicine Excellence in Diversity and Inclusion Award and the Division of Cardiology R. Wayne Alexander Research Mentoring Award. As a cardiovascular epidemiologist, she seeks to forge links between preventive medicine, public policy, quality improvement, and scientific research. She is a Fellow of the American College of Physicians, American College of Cardiology, and American Heart Association. She is the Vice President of Health Awareness Initiative, Africa, a nonprofit organization whose mission is to promote healthy lifestyles in African communities by creating health awareness through screening and education.
Debra Houry, MD, MPH
Chief Medical Officer and Deputy Director for Program and Science at CDC. In this role, she is responsible for establishing, strengthening, and maintaining collaboration and coordination across CDC’s national centers including infectious diseases, chronic disease, environmental health, injury prevention, and public health infrastructure. She also provides overall direction to, and coordination of, the scientific and medical programs. Dr. Houry is also the Designated Federal Officer for the Advisory Committee to the CDC Director, working directly with private and public sector constituents to prioritize CDC’s activities and address key areas including data modernization and health disparities. As a board-certified emergency physician, she has seen firsthand the impact of infectious diseases, chronic health conditions, and injuries on individuals, families, and communities and strives to address and prevent challenges with implementable, evidence-based practices. Prior to this role, Dr. Houry served for nearly two years (2021-2023) as CDC’s acting Principal Deputy Director, overseeing improvements to lab quality, updating global health strategy and governance, and elevating cross-cutting initiatives across the agency such as social determinants and mental health. She was also a key leader in the CDC Moving Forward 5 reorganization process for the agency. She previously served as vice chair and tenured associate professor in the Department of Emergency Medicine at Emory University School of Medicine and as associate professor in the Rollins School of Public Health. Dr. Houry also served as an attending physician at Grady Memorial Hospital in the emergency department and in the medication assisted treatment clinic for opioid use disorder. Dr. Houry received her MD and MPH degrees from Tulane University and completed her residency training in emergency medicine at Denver Health Medical Center.
Jerome Adams, MD, MPH, FASA
Dr. Jerome Adams was appointed a Presidential Fellow and the Executive Director of Purdue’s Health Equity Initiatives on October 1, 2021. He is also a Distinguished Professor of Practice in Pharmacy Practice and Public Health departments. As the 20th U.S. Surgeon General and a prior member of the President’s Coronavirus task force, Dr. Adams has been at the forefront of America’s most pressing health challenges. A regular communicator via TV, radio, and in print, Dr. Adams is an expert not just in science, but also in communicating science to the lay public and making it relevant to various audiences. Dr. Adams is a licensed anesthesiologist with a master’s degree in public health and ran the Indiana State Department of Health prior to becoming Surgeon General. In the State Health Commissioner role, he managed a $350 million dollar budget and over 1000 employees, and led Indiana’s response to Ebola, Zika, and HIV crises. Notably, Dr. Adams helped convince the Governor and State Legislature to legalize syringe service programs in the state, and to prioritize $13 million in funding to combat infant mortality. As Surgeon General, Dr. Adams was the operational head of the 6000-person Public Health Service Commissioned Corps, and oversaw responses to 3 back-to-back category 5 hurricanes, and to a once-in-a-century pandemic. In addition to his recent COVID-19 work, Dr. Adams has partnered with and assisted organizations as they navigate the opioid epidemic, maternal health, rising rates of chronic disease, the impacts of rising suicide rates in our Nation, and how businesses can become better stewards and stakeholders in promoting community health.
Ezekiel J. Emanuel, MD, PhD
Dr. Emanuel is an oncologist and world leader in health policy and bioethics. He is a Special Advisor to the Director General of the World Health Organization, Senior Fellow at the Center for American Progress, and member of the Council on Foreign Relations. He was the founding chair of the Department of Bioethics at the National Institutes of Health and held that position until August of 2011. From 2009 to 2011, he served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. In this role, he was instrumental in drafting the Affordable Care Act (ACA). Emanuel also served on the Biden-Harris Transition Covid Advisory Board. Dr. Emanuel is the most widely cited bioethicist in history. He has over 350 publications and has authored or edited 15 books. His recent books include the books Which Country Has the World’s Best Health Care (2020), Prescription for the Future (2017), Reinventing American Health Care: How the Affordable Care Act Will Improve our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System (2014) and Brothers Emanuel (2013).
Dr. Emanuel regularly contributes to the New York Times, the Washington Post, the Wall Street Journal, The Atlantic, and often appears on BBC, NPR, CNN, MSNBC, and other media outlets. He has received numerous awards including election to the Institute of Medicine (IOM) of the National Academy of Science, the American Academy of Arts and Sciences, the Association of American Physicians, and the Royal College of Medicine (UK). He received –but refused— a Fulbright Scholarship. Most recently he became a Guggenheim Fellow. He has been named a Dan David Prize Laureate in Bioethics and is a recipient of the AMA-Burroughs Wellcome Leadership Award, the Public Service Award from the American Society of Clinical Oncology, Lifetime Achievement Award from the American Society of Bioethics and Humanities, the Robert Wood Johnson Foundation David E. Rogers Award, President’s Medal for Social Justice Roosevelt University, and the John Mendelsohn Award from the MD Anderson Cancer Center. Dr. Emanuel has received honorary degrees from Icahn School of Medicine at Mount Sinai, Union Graduate College, the Medical College of Wisconsin, and Macalester College. Dr. Emanuel is a graduate of Amherst College. He holds a M.Sc. from Oxford University in Biochemistry and received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University.
Janet Wright, MD
Dr. Wright was appointed director in the Division for Heart Disease and Stroke Prevention in July 2021, following a two-year detail in the Office of the Surgeon General as Director of Science and Policy and almost eight years as the inaugural executive director of Million Hearts. She received the 2020 Surgeon General’s Award for Exemplary Service. Before federal service, Dr. Wright led Science and Quality Division at ACC and practiced cardiology in Northern California for 23 years.
Dr. Wright received her MD from the University of Tennessee Health Sciences Center and completed her internal medicine residency at Children’s Hospital and Adult Medical Center and her fellowship in cardiology at San Francisco General Hospital and the University of California, San Francisco.
Kyu Rhee, MD, MPP
Dr. Kyu (“Q”) Rhee is a purpose-driven physician executive and entrepreneur who has served as chief physician executive and Chief Medical Officer at CVS Health, IBM, HRSA, and Community Health Centers. He is a primary care and public health physician who has worked in the nonprofit, public, and private sectors to improve the health system, especially for underserved and health disparity populations. Dr. Rhee serves as the President and CEO of the National Association of Community Health Centers (NACHC). Dr. Rhee leads the organization in advancing health equity and supporting the mission of community health centers, which provide high-quality, affordable, transdisciplinary primary care services to more than 30 million people at over 14,000 sites across the nation.
Dr. Rhee most recently served as Senior Vice President and Aetna Chief Medical Officer at CVS Health. Prior to that, he was Chief Health Officer at IBM for a decade. Before IBM, Dr. Rhee was Chief Public Health Officer at the Health Resources and Services Administration, the primary federal agency for improving access to healthcare services for people who are uninsured, isolated, or medically vulnerable. Dr. Rhee also previously served as director of the Office of Innovation and Program Coordination at the National Institutes of Health, the primary federal agency for medical research. Before his public service, Dr. Rhee was a primary care physician for the National Health Service Corps and served as Chief Medical Officer for Unity Healthcare and Baltimore Medical System.
Jaime Murillo, MD
Dr. Murillo is a Senior VP and Chief Medical Officer at UnitedHealth Group Enterprise Strategy and Innovation. He is focused on the intersectionality of community engagement, chronic disease, technology, and health equity. He recently built a disruptive care delivery solution to improve health in the community using AI-powered technology, social-behavioral determinants of health, and communitybased partnerships. His work also includes advanced analytics to identify gaps in care as well as AI/ML-based phenotyping and multi-omics to advance precision medicine. Prior to his current role at UHG Strategy and Innovation, he was an SVP and Chief CardioMetabolic Health Officer at Optum Labs, the R&D arm of UnitedHealth Group. He started his journey at UHG as UnitedHealthcare’s national lead for cardiovascular and ED services. This work was focused on simple innovation, valuebased transformation, and affordability. He is a cardiologist from Yale University with a background in computer sciences as well as basic science and clinical research at Harvard Medical School and outcomes research at Yale University. He is a former IBM Watson Health collaborator on the clinical implementation of machine learning in the cardiovascular field. He practiced cardiology with a subspecialty in imaging for 20 years at Sentara Health. Within Sentara, he played several executive roles with a focus on leadership development and consumer strategies.